SOPHiA GENETICS
Generated by Meeveem AI
"Delivering AI-driven insights that democratize precision medicine for cancer and rare disorders"
About SOPHiA GENETICS
SOPHiA GENETICS is a publicly traded healthtech company using AI to analyze complex health data for precision medicine. The SOPHiA DDM™ platform processes genomics, radiomics, and multimodal data to generate actionable insights for oncology and rare inherited disorders. Founded in 2011, it connects 990 healthcare institutions across 75 countries, processing over 36,000 genomic profiles monthly. The platform serves clinicians, pathologists, geneticists, and biopharma partners, enabling precise diagnosis and treatment of cancer and rare diseases. By decentralizing data-driven medicine, SOPHiA GENETICS empowers providers worldwide to make informed decisions while maintaining data ownership and compliance.
415
Team Members
2011
Founded
Digital Health
Sector
Hybrid
Work Environment
Our Vision
A future where every patient, regardless of location or circumstance, has equal access to world-class, precision care informed by global health data and artificial intelligence.
Our Mission
At SOPHiA GENETICS, our mission is to transform patient care by expanding access to data-driven medicine globally.